Advances in peptide drug development and the rising prevalence of hematological disorders are driving demand for peptide-based therapeu ...

The incidence and prevalence of genital herpes simplex virus (HSV) type 1 and 2 infections are high worldwide, contributing ...

The blow fill seal technology market is expected to grow from its estimated USD 3,107.8 million in 2024 to USD 5,258.5 million in 2034. Between 2024 and 2034, sales are expected to increase at a ...

Pascal Soriot is stuck in a Chinese limbo. In recent months, the CEO of $205 billion drug giant AstraZeneca has seen his ...

Nine months out from landing $35 million in seed funding, Relation has more news – a big pharma collaboration. The group has ...

AstraZeneca and Daiichi Sankyo shared the pooled analysis behind the refiling of their TROP2 antibody-drug conjugate (ADC) ...

GSK has made the decision to withdraw Jesduvroq (daprodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, from the US market.

Updated results from the DREAMM-7 trial support the use of belantamab mafodotin plus bortezomib and dexamethasone “as a potential new standard of care,” according to Vania Hungria, MD, PhD.

Austin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Autoimmune Disease Therapeutics Market Size & Growth Analysis: “According to SNS Insider, The Global Autoimmune Disease Therapeutics Market was valued at USD ...

DelveInsight's Hematology Market Insights report provides the current and forecast market analysis, individual leading ...

Saudi Arabia Pharmaceutical Drugs Market Set To Witness Significant Growth By 2024-2031:Pfizer Inc.,Sanofi S. A.,Beigene Saudi Arabia Pharmaceutical Drugs Market is estimated to be valued at US$ 12.60 ...

The hematology market is experiencing significant growth driven by the increasing prevalence of blood-related disorders, advancements in research and product development, and the rising number ...